- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Supriya Lifescience Ltd (SPRL)
The Supriya Lifescience share price today is 632.10, view NSE SPRL stock exchange data. Track the latest Supriya Lifescience share price with real-time updates on SPRL stock performance including market cap, day range, 52-week range and dividend yield. Access SPRL charts, earnings dates and analyst estimates to support your investment decisions.
632.10
-9.95(-1.55%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
631.00
646.40
52 wk Range
545.50
1,085.00
SUPRIYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
631.00646.40
52 wk Range
545.501,085.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SUPRIYA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
765.00
Upside
+21.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 765.00
(+21.03% Upside)
Earnings
Latest Release
06-11-2026
EPS / Forecast
3.60 / --
Revenue / Forecast
2.06B / --
Compare SUPRIYA to Peers and Sector
Metrics to compare | SUPRIYA | Peers Peers - average of corresponding metrics from companies closely matching SUPRIYA: CAPLIPOINT, GRANULES, SHILPAMED, ACUTAAS, MOREPENLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSUPRIYAPeersSector |
|---|---|---|---|---|
P/E Ratio | 28.7x | 29.2x | −0.2x | |
PEG Ratio | −9.58 | 0.54 | 0.00 | |
Price/Book | 4.1x | 3.8x | 2.6x | |
Price / LTM Sales | 5.8x | 3.5x | 2.8x | |
Upside (Analyst Target) | 21.0% | 11.1% | 63.4% | |
Fair Value Upside | Unlock | −8.6% | 9.5% | Unlock |
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals in India and internationally. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides finished formulation products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it develops drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Supriya Lifescience (SUPRIYA) Share Price Today?
The Supriya Lifescience share price today is 632.10.
What is the current Supriya Lifescience (SUPRIYA) share price and day range?
As of 13-11-2026, the Supriya Lifescience share price is 632.10, with a previous close of 632.10. The share price has ranged from 631.00 to 646.40 today, while the 52-week range spans from 545.50 to 1,085.00.
What Is the Supriya Lifescience Market Cap?
As of today, Supriya Lifescience market cap is 50.87B.
Does Supriya Lifescience Pay Dividends? What's The Current Dividend Yield?
The Supriya Lifescience dividend yield is 0.2%%.
What Is the Supriya Lifescience (SUPRIYA) Share Price Target?
The average 12-month share price target for Supriya Lifescience is 765.00, with a high estimate of 850 and a low estimate of 680. 1 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and +21.03% Upside potential.
What Is Supriya Lifescience's Earnings Per Share (TTM)?
The Supriya Lifescience EPS (TTM) is 22.01.
From a Technical Analysis Perspective, Is SUPRIYA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Supriya Lifescience Trade On?
Supriya Lifescience is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Supriya Lifescience?
The stock symbol for Supriya Lifescience is "SUPRIYA."
How Many Times Has Supriya Lifescience Stock Split?
Supriya Lifescience has split 0 times.
How Many Employees Does Supriya Lifescience Have?
Supriya Lifescience has 607 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.